Initially, we selected the classical aiPLA2 inhibitor MJ33 for the KA‐induced epilepsy model involving D2HGDH knockdown.[29, 35] Consecutive daily intraperitoneal injections of MJ33 were administered for 7 d before KA injection (Figure6A). This evidence concerns the gene PRDX6 and epilepsy.